Profile
PRPH ZTS TAK HLN TEVA ITCI
Company Name ProPhase Labs, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $24.73M $63.58B $43.58B $41.55B $23.07B $14.05B
Employees 0.10K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Ted William Karkus Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Sharon Mates
Ratings
PRPH ZTS TAK HLN TEVA ITCI
Quant Rating Score 1 3 3 3 2 1
Quant Rating Strong Sell Neutral Neutral Neutral Sell Strong Sell
Trading
PRPH ZTS TAK HLN TEVA ITCI
Last Close $0.472 $142.12 $13.86 $9.19 $19.78 $131.87
High 52 $2.46 $193.28 $15.52 $11.41 $22.77 $131.91
Low 52 $0.24 $141.11 $12.89 $8.73 $12.82 $75.02
Price vs. 52 Week High -80.81 % -26.47 % -10.7 % -19.46 % -13.13 % -0.03 %
Price vs. 52 Week Low 96.67 % 0.72 % 7.53 % 5.27 % 54.29 % 75.78 %
Total Return
PRPH ZTS TAK HLN TEVA ITCI
1 Month Return 8.71 % -3.61 % -8.33 % -0.97 % 5.89 % 0 %
3 Month Return 26.88 % -6.23 % -5.84 % -5.16 % 23.55 % 0 %
6 Month Return 68.33 % -3.16 % -5.39 % -9.55 % 47.28 % 0 %
9 Month Return -21.33 % -16.09 % 6.21 % 0 % -8.76 % 4.44 %
YTD Return -37.66 % -12.77 % 4.68 % -3.67 % -10.25 % 57.89 %
1 Year Return -80.66 % -25.59 % -2.81 % -8.83 % 10.13 % 67.6 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PRPH ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.35 % 4.72 % 1.64 % - -
Dividend Paid and Capex Coverage Ration (TTM) -103.24 % 1.89 % 2.01 % 2.01 % 2.78 % -121.31 %
Dividend Per Share (TTM) - 1.93 % 198 % 0.06 % - -
Payout Ratio (TTM) - 32.08 % 226.17 % 27.27 % - -
Profitability
PRPH ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 60.45 % 70.03 % 52.77 % 61.81 % 49.6 % 91.22 %
Return on Assets TTM -98.6 % 18.04 % 0.98 % 4.78 % -0.39 % -4.35 %
Return on Equity TTM -230.18 % 53.21 % 1.95 % 9.4 % -2.58 % -5.19 %
Return on Capital Employed TTM -183.13 % 31.67 % 4.8 % 8.34 % 3.16 % -8.25 %
Net Income Per EBT TTM 124 % 78.72 % 72.4 % 76.52 % 222.54 % 100.19 %
EBT Per Ebit TTM 111.21 % 94.26 % 33.29 % 88.09 % -7.94 % 61.94 %
EBIT Per Revenue TTM -900.03 % 37.51 % 12.68 % 20.49 % 5.38 % -17.88 %
Cash Flow To Debt Ratio TTM -109.93 % 43.13 % 22.35 % 12.02 % 7.93 % -230.03 %
Receivables Turnover TTM 0.17 6.09 6.59 5.14 4.67 3.22
Payables Turnover TTM 0.09 5.54 5.02 1.18 3.35 1.8
Inventory Turnover TTM 1.59 1.15 1.71 3.72 2.4 1.79
Fixed Asset Turnover TTM 92.11 % 244.46 % 229.02 % 589.57 % 321.73 % 3596.74 %
Asset Turnover TTM 7.94 % 64.82 % 31.99 % 34.62 % 41.43 % 39.2 %
Operating Cash Flow Per Share TTM -0.15 6.58 643.53 0.11 1.21 -0.38
Free Cash Flow Per Share TTM -0.15 4.99 521.29 0.1 0.78 -0.38
Cash Per Share TTM 0.41 % 322.4 % 22368.59 % 7.46 % 188.4 % 970.67 %
Operating Cash Flow Sales Ratio TTM -182.37 % 31.21 % 22.48 % 9.32 % 8.36 % -7.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.03 % 75.76 % 81.01 % 90.65 % 64.03 % 100.82 %
Cash Flow Coverage Ratios TTM -109.93 % 43.13 % 22.35 % 12.02 % 7.93 % -230.03 %
Price To Free Cash Flows Ratio TTM -4.1 28.65 8.04 32.81 26.04 -356.68
Price To Operating Cash Flows Ratio TTM -4.06 21.8 6.52 30.24 16.67 -348.17
Price Cash Flow Ratio TTM -4.06 21.8 6.52 30.24 16.67 -348.17
Income Statement (TTM)
PRPH ZTS TAK HLN TEVA ITCI
Revenue $0.01B $9.26B $4581.55B $11.23B $16.54B $0.68B
Gross Profit $-0B $6.4B $3001.33B $6.95B $8.06B $0.62B
Gross Profit Ratio -2.22% 69.1% 65.51% 61.85% 48.74% 91.63%
EBITDA $-0.03B $3.87B $1210.51B $2.51B $0.78B $-0.12B
Net Income $-0.05B $2.49B $107.93B $1.44B $-1.64B $-0.07B
EPS Diluted -2.61 5.47 33.62 0.32 -1.45 -0.72
Balance Sheet (MRQ)
PRPH ZTS TAK HLN TEVA ITCI
Long Term Debt $0.02B $5.39B $4517.23B $8.62B $16.3B $0.01B
Total Liabilities $0.06B $9.47B $7312.37B $18.09B $33.61B $0.22B
Total Equity $0.01B $4.77B $6935.98B $16.22B $5.72B $1.15B
Total Investments $0B $0B $10.8B $0.08B $0B $0.69B
Total Debt $0.02B $6.74B $5066.17B $10.1B $18.08B $0.02B
Total Assets $0.06B $14.24B $14248.34B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
PRPH ZTS TAK HLN TEVA ITCI
Net Income $-0.05B $2.5B $107.93B $1.44B $-1.96B $-0.07B
Inventory $0B $-0.04B $-34.97B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $-0.02B $2.95B $1057.18B $2.3B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-200.8B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.28
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 2.23
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 8.665
ALVOW Alvotech 1.53
AMPH Amphastar Pharmaceuticals, Inc. 23.21
AMRX Amneal Pharmaceuticals, Inc. 9.875
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 91.86
APUS Apimeds Pharmaceuticals US, Inc 1.84
AQST Aquestive Therapeutics, Inc. 7.045
ASRT Assertio Holdings, Inc. 0.8249
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 14.885
ETFs With Exposure to PRPH
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 325.65
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00022 144.545
VXF Vanguard Extended Market Index Fund 0.00015 209.1
IWC iShares Micro-Cap ETF 0.00145 155.3
DWAS Invesco DWA SmallCap Momentum ETF 0.34 94.415
EES WisdomTree U.S. SmallCap Earnings Fund 0.0001456 54.39
FDM First Trust Dow Jones Select MicroCap Index Fund 0.13 72.94
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.39 30.95
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 111.65
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 111.63
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.62
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.61
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.62
AVUV Avantis U.S. Small Cap Value ETF 0.01 97.05
AVUS Avantis U.S. Equity ETF 0 107.28
DFAT Dimensional U.S. Targeted Value ETF 0.00006044 56.57
VTSAX Vanguard Total Stock Market Index Fund 0 159.79
AVSU Avantis Responsible U.S. Equity ETF 0 72.69
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00015 161.24
VITSX Vanguard Total Stock Market Index Fund 0 159.82
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.00013003 16.19
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00015 161.25
DFQTX DFA U.S. Core Equity 2 Portfolio 0 43.07
DCOR Dimensional ETF Trust 0.00000164 70.99
VEMPX Vanguard Extended Market Index InstlPlus 0.00015 397.91
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 299.8
Unlock